miR-122 is a powerful tumor suppressor, by inhibiting angiogenesis, tumorigenesis and HCC intrahepatic metastasis, partially by targeting ADAM metallopeptidase domain 17 (ADAM17) [68]. This evidence concerns the gene ADAM17 and neoplasm.